Pharma sector stocks surge today, July 3: Aurobindo Pharma jumps 2.74%, Sudeep Pharma gains 2.43%, Lupin up 1.95%

Indian pharma sector stocks displayed a mixed but largely positive trend in early trading, as of 9:47 AM IST. The S&P BSE Healthcare index rose 1.03% to reach 49,951.86 points. For comparison, the broader market benchmarks also advanced, with the Nifty 50 gaining 0.67% to 24,336.80 and the S&P BSE Sensex increasing 0.72% to 78,060.51.

The provided data covers 22 major pharmaceutical companies listed on BSE and NSE. BSE prices were captured around 9:40 AM, while NSE prices reflect levels near 9:44 AM. Most stocks posted modest to moderate gains, though a couple recorded declines.

Stock Performance Highlights

Notable gainers in early session:

• Aurobindo Pharma led with strong movement: BSE ₹1,593.80 (+2.16%), NSE ₹1,603.70 (+2.74%).
• Sudeep Pharma Ltd. rose BSE ₹876.35 (+2.32%), NSE ₹878.00 (+2.43%).
• Indoco Remedies: BSE ₹247.20 (+1.58%), NSE ₹249.82 (+2.38%).
• Lupin: BSE ₹2,435.50 (+1.53%), NSE ₹2,446.30 (+1.95%).
• Divis Laboratories: BSE ₹6,781.00 (+1.60%), NSE ₹6,788.50 (+1.59%).
• Torrent Pharma: BSE ₹4,733.25 (+1.52%), NSE ₹4,749.30 (+1.89%).
• J.B. Chemicals, Dr. Reddy’s Lab, Sun Pharma, Zydus Lifesciences, Ipca Labs, and Ajanta Pharma all registered gains between 1% and 1.8% on both exchanges.

Other stocks with positive movement included Cipla, Glenmark Pharma, Biocon, Aarti Drugs, Mankind Pharma, Natco Pharma, and Wockhardt, showing increases ranging from 0.29% to 1.45%.

Decliners:

• Orchid Pharma: BSE ₹953.00 (-2.51%), NSE ₹949.95 (-3.00%).
• Panacea Biotech: BSE ₹543.75 (-0.66%), NSE ₹547.00 (-0.23%).
• Alembic Pharma showed a minor mixed result with a small gain on BSE but a slight decline on NSE.

Important Note: The figures above represent a snapshot from July 3, 2026 morning trade and should not be considered as final closing values or investment advice. Investors are advised to verify latest prices directly from BSE and NSE official platforms and conduct their own due diligence.